Pdt Partners, LLC Voyager Therapeutics, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 22,163 shares of VYGR stock, worth $128,102. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,163

Previous 75,705 70.72%

Holding current value

$128,102

Previous $598,000 78.43%

% of portfolio

0.01%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $308,937 - $496,334	-53,542 Reduced 70.72%	22,163 $129,000
Q2 2024 Aug 15, 2024	BUY	$7.42 - $10.54 $561,731 - $797,930	75,705 New	75,705 $598,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $48,995 - $102,564	10,165 New	10,165 $60,000
Q1 2022 May 16, 2022	SELL	$2.75 - $9.44 $74,525 - $255,824	-27,100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $25,511 - $39,964	-9,700 Reduced 26.36%	27,100 $71,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $206,290 - $284,827	-52,358 Reduced 58.72%	36,800 $152,000
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $156,007 - $305,922	33,841 Added 61.18%	89,158 $420,000
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $74,824 - $128,510	10,465 Added 23.33%	55,317 $396,000
Q3 2020 Nov 16, 2020	BUY	$10.01 - $13.75 $96,956 - $133,182	9,686 Added 27.54%	44,852 $479,000
Q2 2020 Aug 14, 2020	BUY	$8.05 - $14.21 $283,086 - $499,708	35,166 New	35,166 $444,000
Q1 2020 May 15, 2020	SELL	$6.8 - $14.66 $68,530 - $147,743	-10,078 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.82 - $16.85 $129,199 - $169,814	10,078 New	10,078 $141,000
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $88,270 - $185,481	-10,276 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $1.87 Million - $2.37 Million	-109,224 Reduced 91.4%	10,276 $194,000
Q2 2018 Aug 14, 2018	SELL	$16.76 - $23.92 $487,716 - $696,072	-29,100 Reduced 19.58%	119,500 $2.34 Million
Q1 2018 May 15, 2018	SELL	$16.16 - $31.31 $416,928 - $807,798	-25,800 Reduced 14.79%	148,600 $2.79 Million
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $1.36 Million - $2.88 Million	111,113 Added 175.57%	174,400 $2.9 Million
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $529,712 - $1.3 Million	63,287	63,287 $1.3 Million

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account